The orthodontic space closure (OSC) group consisted of ten patients (six males, four females, mean age 19 ± 2.1 years at the completion of treatment).
The study group consisted of ten patients treated with orthodontic space closure (six males, four females, mean age 19 ± 2.1 years at the completion of treatment) and ten patients treated with implant insertion (five males, five females, mean age 20 ± 1.4 years at the time of implant insertion).
Tenure length for the seven immigrant males ranged from 1.3 to 9.3 years at the completion of the study (median = 3.1 years).
Seventy-five percent of the responders agreed to take part in a more detailed survey; those eligible for inclusion were women, aged between 35 and 69 years at the completion date of the original mail survey.
The mean age at first admission to CAP care was 12.1 (SD 4.1) years, mean age at completion of CAP treatment was 14.1 (SD 3.7) years, and mean age at follow-up was 34.1 (SD 4.9) years.
In the same study, they noted that the patients' health status remained well below normal population means even at 2 years after completion of treatment.
The Finnish Diabetes Prevention Study, however, found a weight regain of around 33% at 2 years after completion of the intervention.
At 3 years after completion of radiotherapy, no significant differences were observed between the young patients and the young women from the reference population (P>0.010).
Most quality of life studies included in the review assessed HRQoL within the first year following treatment; however two studies assessed the impact of SVR at >3 years after completion of antiviral therapy.
To test for mean differences in HRQoL between the prediction scores of young breast cancer patients and the young reference population at 3 years after completion of radiotherapy, a T-test was used.
Institutional engagement, as reflected by infection control teams' perception of management's actions to support the campaign, was reported to be high, even at three years after completion of national roll out.
